Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1%

NCT05213585 is registered in ClinicalTrials.gov with Helm Vision Group as lead sponsor.

NCT NCT05213585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05213585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1%
Lead sponsor
Helm Vision Group
Phase
Phase 3
Overall status
Completed
Start date
August 24, 2021
Completion date
December 31, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the focus of the study is to assess the effectiveness of topical ivermectin on eliminating eyelash sleeves